Literature DB >> 7604144

Dissociations between the locomotor stimulant and depressant effects of nicotinic agonists in rats.

I P Stolerman1, H S Garcha, N R Mirza.   

Abstract

The effects of nicotine and related compounds on locomotor activity were compared in experimentally naive rats and in animals chronically exposed to nicotine and the photocell test chambers. In experimentally naive rats, all nicotinic compounds decreased locomotion in a dose-related manner and the rank order of potency was (-)-nicotine > (+)-nornicotine > (+)-nicotine > cytisine > lobeline > anabasine. Mecamylamine attenuated the locomotor depressant effects of most of the agonists, except lobeline. In rats previously exposed to nicotine and the test apparatus for several weeks, (-)-nicotine increased locomotor activity in a dose-related manner, with a maximal increase to 400% of baseline at a dose of 0.4 mg/kg. One or more doses of (+)-nicotine, (+)-nornicotine and anabasine also increased locomotor activity in these animals, although the maximal effects seen were in all cases less than the maximal effect of (-)-nicotine. Cytisine and lobeline failed to increase locomotor activity at any dose tested. These conclusions were not altered by consideration of the time-courses for the effects of the different drugs. Thus, the results confirm that the locomotor stimulant and depressant effects of nicotine can be dissociated from each other, a finding that may be explained by differences in their actions at nicotinic receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7604144     DOI: 10.1007/BF02246215

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

Review 1.  The fall and rise of neuronal alpha-bungarotoxin binding proteins.

Authors:  P B Clarke
Journal:  Trends Pharmacol Sci       Date:  1992-11       Impact factor: 14.819

Review 2.  Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors.

Authors:  E S Deneris; J Connolly; S W Rogers; R Duvoisin
Journal:  Trends Pharmacol Sci       Date:  1991-01       Impact factor: 14.819

3.  Acute and chronic tolerance to nicotine measured by activity in rats.

Authors:  I P Stolerman; R Fink; M E Jarvik
Journal:  Psychopharmacologia       Date:  1973-06-29

4.  Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline.

Authors:  C Reavill; B Walther; I P Stolerman; B Testa
Journal:  Neuropharmacology       Date:  1990-07       Impact factor: 5.250

5.  Variation of nicotinic binding sites among inbred strains.

Authors:  M J Marks; E Romm; S M Campbell; A C Collins
Journal:  Pharmacol Biochem Behav       Date:  1989-07       Impact factor: 3.533

6.  Isoarecolone can inhibit nicotine binding and produce nicotine-like discriminative stimulus effects in rats.

Authors:  C Reavill; C E Spivak; I P Stolerman; J A Waters
Journal:  Neuropharmacology       Date:  1987-07       Impact factor: 5.250

7.  Role of training dose in discrimination of nicotine and related compounds by rats.

Authors:  I P Stolerman; H S Garcha; J A Pratt; R Kumar
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  The effects of nicotine on locomotor activity in non-tolerant and tolerant rats.

Authors:  P B Clarke; R Kumar
Journal:  Br J Pharmacol       Date:  1983-02       Impact factor: 8.739

9.  Selective antagonism of nicotine actions in the rat cerebellum with alpha-bungarotoxin.

Authors:  R de la Garza; T J McGuire; R Freedman; B J Hoffer
Journal:  Neuroscience       Date:  1987-12       Impact factor: 3.590

10.  Exposure to nicotine enhances the behavioral stimulant effect of nicotine and increases binding of [3H]acetylcholine to nicotinic receptors.

Authors:  C Ksir; R Hakan; D P Hall; K J Kellar
Journal:  Neuropharmacology       Date:  1985-06       Impact factor: 5.250

View more
  32 in total

1.  The effects of lobeline on nicotine withdrawal-induced depression-like behavior in mice.

Authors:  Monzurul Amin Roni; Shafiqur Rahman
Journal:  Psychopharmacology (Berl)       Date:  2014-02-28       Impact factor: 4.530

2.  The reinforcement enhancing effects of nicotine depend on the incentive value of non-drug reinforcers and increase with repeated drug injections.

Authors:  Matthew I Palmatier; Gina L Matteson; Jessica J Black; Xiu Liu; Anthony R Caggiula; Laure Craven; Eric C Donny; Alan F Sved
Journal:  Drug Alcohol Depend       Date:  2007-01-19       Impact factor: 4.492

3.  Status and Future Directions of Preclinical Behavioral Pharmacology in Tobacco Regulatory Science.

Authors:  Mark G LeSage; John R Smethells; Andrew C Harris
Journal:  Behav Anal (Wash D C)       Date:  2018-07-09

Review 4.  Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.

Authors:  S Chatterjee; S E Bartlett
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

5.  Environmental enrichment decreases nicotine-induced hyperactivity in rats.

Authors:  Thomas A Green; Mary E Cain; Michael Thompson; Michael T Bardo
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

6.  Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.

Authors:  P B Clarke; M Reuben
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

Review 7.  The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.

Authors:  Sharon R Grady; Outi Salminen; Duncan C Laverty; Paul Whiteaker; J Michael McIntosh; Allan C Collins; Michael J Marks
Journal:  Biochem Pharmacol       Date:  2007-07-27       Impact factor: 5.858

8.  Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats.

Authors:  P Whiteaker; H S Garcha; S Wonnacott; I P Stolerman
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

9.  Restoration of amphetamine-induced locomotor sensitization in dopamine D1 receptor-deficient mice.

Authors:  Mufida B El-Ghundi; Theresa Fan; Joanna M Karasinska; John Yeung; Millee Zhou; Brian F O'Dowd; Susan R George
Journal:  Psychopharmacology (Berl)       Date:  2009-10-15       Impact factor: 4.530

10.  Differential induction of ethanol-metabolizing CYP2E1 and nicotine-metabolizing CYP2B1/2 in rat liver by chronic nicotine treatment and voluntary ethanol intake.

Authors:  Jiang Yue; Jibran Khokhar; Sharon Miksys; Rachel F Tyndale
Journal:  Eur J Pharmacol       Date:  2009-03-13       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.